ES2054899T3 - Derivados de 2'-desoxi-5-fluorouridina. - Google Patents

Derivados de 2'-desoxi-5-fluorouridina.

Info

Publication number
ES2054899T3
ES2054899T3 ES89103261T ES89103261T ES2054899T3 ES 2054899 T3 ES2054899 T3 ES 2054899T3 ES 89103261 T ES89103261 T ES 89103261T ES 89103261 T ES89103261 T ES 89103261T ES 2054899 T3 ES2054899 T3 ES 2054899T3
Authority
ES
Spain
Prior art keywords
group
chem
formula
acyl
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89103261T
Other languages
English (en)
Inventor
Tsutomu Kawai
Fumio Mori
Setsuo Takeda
Hitoshi Saito
Norio Unemi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2054899T3 publication Critical patent/ES2054899T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS DEL 2'' - DEOXI - 5 - FLUORIDINA DE FORMULA: DONDE , R1 ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUIL Y R2 Y R3 SON RESPECTIVAMENTE UN ATOMO DE HIDROGENO, UN GRUPO ACIL O UN GRUPO DE FORMULA: DONDE X1 Y X2 SON RESPECTIVAMENTE UN ATOMO DE OXIGENO O UN ATOMO DE AZUFRE; R4 ES UN GRUPO FENIL, UN GRUPO BENCIL, O UN GRUPO NAFTIL CADA UNO DE LOS CUALES PUEDE SER SUBSTITUIDO POR UN GRUPO ALQUIL, UN GRUPO ACIL, UN ATOMO HALOGENO, UN GRUPO TRIFMOROMETIL, UN GRUPO NITRO, UN GRUPO CIANO, UN GRUPO CARBOXIL Y/O UN GRUPO METILENEDIOXI Y R5 ES UN GRUPO ALQUIL, UN GRUPO ALQUENIL O UNO DE LOS GRUPOS REPRESENTADOS PO R4 EN CUAL ES EL MISMO O DIFERENTE DE R4 EL CUAL ES EL MISMO O DIFERENTE DE R4, AL MENOS UNO DEL R2 O R3 SITUADO UN GRUPO DE FORMULA: EL CUAL PRESENTA EXCELENTE ACTIVIDADES ANTITUMORALES Y TIENE UNA TOXICIDAD INFERIOR, LOS METODOS DE LA PRODUCCION Y LOS COMPUESTOS ANTITUMORALES CONTENIENDO DICHOS DERIVADOS DEL 2'' - DEOXI - 5 - FLUORORIDINA.
ES89103261T 1988-02-29 1989-02-24 Derivados de 2'-desoxi-5-fluorouridina. Expired - Lifetime ES2054899T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4786488 1988-02-29

Publications (1)

Publication Number Publication Date
ES2054899T3 true ES2054899T3 (es) 1994-08-16

Family

ID=12787236

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89103261T Expired - Lifetime ES2054899T3 (es) 1988-02-29 1989-02-24 Derivados de 2'-desoxi-5-fluorouridina.

Country Status (9)

Country Link
US (1) US5032680A (es)
EP (1) EP0331032B1 (es)
KR (1) KR890013009A (es)
CN (1) CN1024349C (es)
AT (1) ATE88714T1 (es)
AU (1) AU610344B2 (es)
CA (1) CA1313661C (es)
DE (1) DE68906183T2 (es)
ES (1) ES2054899T3 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250673A (en) * 1983-05-23 1993-10-05 Taiho Pharmaceutical Company, Ltd. 2'-deoxy-5-substituted uridine derivatives
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
DE4015715A1 (de) * 1990-05-16 1991-11-21 Bayer Ag Neuartige oligophosphate mit antiviraler wirkung
US5627165A (en) * 1990-06-13 1997-05-06 Drug Innovation & Design, Inc. Phosphorous prodrugs and therapeutic delivery systems using same
EP0533833B1 (en) * 1990-06-13 1995-12-20 GLAZIER, Arnold Phosphorous produgs
US5272152A (en) * 1990-07-02 1993-12-21 E. R. Squibb & Sons, Inc. Purinyl and pyrimidinyl tetrahydrofurans
EP0481214B1 (en) * 1990-09-14 1998-06-24 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Prodrugs of phosphonates
US5233031A (en) * 1991-09-23 1993-08-03 University Of Rochester Phosphoramidate analogs of 2'-deoxyuridine
US5314893A (en) * 1993-01-25 1994-05-24 Bristol-Myers Squibb Co. Antiviral tetrahydropyrans
JP2526414B2 (ja) * 1994-05-20 1996-08-21 工業技術院長 制ガン剤エステル化合物及びその製造方法
US5808045A (en) * 1994-09-02 1998-09-15 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
US5990300A (en) * 1994-09-02 1999-11-23 Andrew C. Hiatt Enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
US5872244A (en) * 1994-09-02 1999-02-16 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
US6214987B1 (en) 1994-09-02 2001-04-10 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides
US6232465B1 (en) 1994-09-02 2001-05-15 Andrew C. Hiatt Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
US5763594A (en) * 1994-09-02 1998-06-09 Andrew C. Hiatt 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US6872710B2 (en) * 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
TW593331B (en) * 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
WO2000077014A1 (en) * 1999-06-11 2000-12-21 Kyowa Hakko Kogyo Co., Ltd. Aryl phosphates
DE10313035A1 (de) * 2003-03-24 2004-10-07 Resprotect Gmbh Methode zur Verstärkung der apoptotischen Wirkung von Zytostatika ohne Erhöhung toxischer Nebenwirkungen
EP2136626A4 (en) * 2007-03-19 2011-02-23 Oregon State Mannich base n-oxide drugs
WO2009042064A2 (en) 2007-09-21 2009-04-02 Nektar Therapeutics Al, Corporation Oligomer-nucleoside phosphate conjugates
CN101440111B (zh) * 2008-12-22 2011-06-22 西安交通大学 一种抗肿瘤化合物及其制备方法
CN110156838A (zh) * 2013-05-14 2019-08-23 北京美倍他药物研究有限公司 磷酸/膦酸衍生物及其医药用途
CN110678473A (zh) * 2017-04-25 2020-01-10 大原药品工业株式会社 核苷类抗癌药或抗病毒药的5’位二苄基单磷酸酯衍生物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535057A (en) * 1978-09-05 1980-03-11 Funai Corp 2'-deoxy-5-fluorouridine derivative, its preparation, and antitumor agent comprising it
JPS56115799A (en) * 1980-02-15 1981-09-11 Funai Corp 2'-deoxy-3',5'-di-o-alkylcarbonyl-5-fluorouridine derivative, its preparation, and antitumor agnet containing the same
JPS57128699A (en) * 1981-02-03 1982-08-10 Tokyo Kinzoku Kogyo Kk 5-fluorouracil derivative and its medical composition
EP0081386B1 (en) * 1981-12-09 1985-05-29 Teijin Limited 5-fluoro-2'-deoxyuridine derivatives and a process for the preparation thereof
JPS5970699A (ja) * 1982-10-13 1984-04-21 Teijin Ltd ５−フルオロ−２′−デオキシウリジン誘導体及びその製造法
JPS5899499A (ja) * 1981-12-09 1983-06-13 Teijin Ltd ５−フルオロ−２′−デオキシウリジン誘導体を有効成分とする抗腫瘍剤
JPS5993096A (ja) * 1982-11-19 1984-05-29 Teijin Ltd ５−フルオロ−２′−デオキシウリジン誘導体及びその製造法
JPS6191196A (ja) * 1984-10-09 1986-05-09 Toyama Chem Co Ltd 新規な５―フルオロ―２´―デオキシウリジン―５´―ホスフェート誘導体およびその塩並びにそれらを含有する抗腫瘍剤
US4684631A (en) * 1984-10-09 1987-08-04 Toyama Chemical Co., Ltd. Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for producing the same, and antitumor agents containing the same
JPS6191195A (ja) * 1984-10-12 1986-05-09 Toyama Chem Co Ltd 新規な５−フルオロ−２′−デオキシウリジン−５′−ホスフエ−ト誘導体およびその塩
JPS61152694A (ja) * 1984-12-27 1986-07-11 Toyama Chem Co Ltd 新規な５−フルオロ−２′−デオキシウリジン−５′−ホスフエ−ト誘導体およびその塩
JPS61236793A (ja) * 1985-04-15 1986-10-22 Toyo Jozo Co Ltd 新規リン脂質・ヌクレオシド誘導体

Also Published As

Publication number Publication date
KR890013009A (ko) 1989-09-20
AU610344B2 (en) 1991-05-16
ATE88714T1 (de) 1993-05-15
CA1313661C (en) 1993-02-16
AU3015289A (en) 1989-08-31
EP0331032A1 (en) 1989-09-06
EP0331032B1 (en) 1993-04-28
CN1045395A (zh) 1990-09-19
DE68906183T2 (de) 1993-09-02
DE68906183D1 (de) 1993-06-03
CN1024349C (zh) 1994-04-27
US5032680A (en) 1991-07-16

Similar Documents

Publication Publication Date Title
ES2054899T3 (es) Derivados de 2'-desoxi-5-fluorouridina.
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
ATE132134T1 (de) Benzamide
FI956270A0 (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI953968A0 (fi) Antraniiliset happojohdannaiset
NO305318B1 (no) Heterocykliske forbindelser og anvendelser derav
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
ATE126517T1 (de) Verwendung von bis(3,4- dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen.
DE68920796D1 (de) Chinolinderivate, ihre Herstellung und Verwendung.
NO301980B1 (no) 2,3-dihydro-1,4-benzodioksin-5-yl-piperazinderivater med 5-HT1A-antagonistisk aktivitet og farmasöytisk sammensetning inneholdende dem
FI900146A0 (fi) Akrylaattifungisidi ja niiden käyttö
DE69717453D1 (de) Amid derivate
EA199801006A1 (ru) Бициклические амины в качестве инсектицидов
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
CA2273303A1 (en) Thienylsulfonylamino(thio)carbonyl compounds
KR970702848A (ko) 아릴피페리딘 및 아릴피페라진 유도체 및 이를 함유하는 약제(Arylpiperidine and arylpiperazine derivatives and drugs containing the same)
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
IT1216522B (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.
IT1241988B (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
ATE119523T1 (de) Isochinolinderivate und ihre salze als proteasehemmer.
DE3781783D1 (de) N-alkyl-derivate von 2-amino-6,7-dimethoxytetralin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen mit antihypertensiver wirkung.
DE69626624D1 (de) Medikamente gegen trhombocytopenie
MY104164A (en) Heterocyclic compounds.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 331032

Country of ref document: ES